Abstract:The authors wish to correct three product structures in their Communication. The three structures (2ag–2ai) in Table 2, which were originally identified as γ-aminoketone hydrochlorides, are actually their intramolecular dehydrated condensation derivative hydrochlorides. The original structures and the corrected structures are shown below. The reaction of ketoxime ethers 1ag–1ai first delivered linear γ-aminoketone hydrochlorides (the original structures), which can spontaneously undergo condensation to form cyclic imine hydrochlorides. The obtained products 2ag–2ai were initially characterized as γ-aminoketone hydrochlorides on the basis of NMR spectra and HRMS data. However, single-crystal X-ray diffraction analysis of 2ah shows that it has the structure of a cyclic imine hydrochloride. There is an equilibrium between the linear γ-aminoketone hydrochloride and its dehydrated cyclic imine hydrochloride in solvent (D2O, DMSO-D6, and CD3OD), which tpredominantly favors dehydration. Although γ-aminoketone hydrochlorides can be detected by HRMS, only cyclic imine hydrochlorides were isolated in pure form. The related description “Significantly, this tactic was also feasible to 1,5-amino migration by employing ketoxime ethers 1ag–1ai and the desired trifluoromethyl substituted γ-aminoketones 2ag–2ai were successfully generated in moderate yields.” should be corrected to “Significantly, this tactic was also feasible to 1,5-amino migration by employing ketoxime ethers 1ag–1ai, and the desired trifluoromethyl substituted γ-aminoketones were successfully generated in moderate yields; the latter readily underwent intramolecular condensation to afford cyclic imine hydrochlorides 2ag–2ai.” HRMS data of 2ag–2ai in the form of dehydrated cyclic structures, X-ray diffraction structure of 2ah, and characterization data of the unhydrolyzed 1,5-amino migration products 2ag’–2ai’ have been updated in the Supporting Information provided with this Corrigendum. The authors apologize for the inconvenience caused by this mistake and underline that this Corrigendum has no impact on the conclusion of the article. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Corrigendum to ‘Novel stereoselective synthesis of 1-(β-D- and α-L-glycopyranosyl)-5-methyl-1H-1,2,4-triazoles’

Novel Stereoselective Synthesis of 1-(Β-d- and Α-L-glycopyranosyl)-5-methyl-1h-1,2,4-triazoles

Synthesis of Some Novel Glucosyl Triazoles from 2,3,4,6-Tetra-o-pivaloyl-d-glucopyranosylazide

Studies on Condensed Heterocyclic Compounds: Part Xviii - Synthesis of 6-(1-aryl-5-methyl-1,2,3-triazol-4-yl)-3-(4-pyridyl)-s-triazolo[3,4-b]-1 ,3,4-Thiadiazoles

Synthesis of N-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)-N '-(mercapto-1,2,4-triazol-4-yl)ureas and N-(3-aryl-5-mercapto-1,2,4-triazol-4-yl)-(1-oxyl-2,2,5,5-tetramethylpyrrolin-3-yl)acidamide

Synthesis of 1,2,3-Triazoles from Azide-Derivatised Aminocyclitols by Catalytic Diazo Transfer and Cuaac Click Chemistry

Corrigendum to “synthesis and in Vitro Pharmacological Studies of New C(4) Modified Salvinorin A Analogues” [bioorg. Med. Chem. Lett. 16 (2006) 5498–5502]

A Novel and Efficient Strategy for the Preparation of 2,4-Disubstituted-1,2,3-triazoles

Another Way to the Synthesis of 1,2,3‐Triazoles

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Berichtigung: Radical 1,4/5‐amino Shift Enables Access to Fluoroalkyl‐Containing Primary Β(γ)‐aminoketones under Metal‐Free Conditions

Correction: Wu et al. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents. Molecules 2018, 23, 2330

Correction: Synthesis of C14–C21 acid fragments of cytochalasin Z<sub>8</sub><i>via anti</i>-selective aldol condensation and <i>B</i>-alkyl Suzuki–Miyaura cross-coupling

Synthesis, Structure and Biological Activity Studies of 2‐[(1h‐1,2,4‐triazol‐1‐yl)methyl]‐1‐aryl)‐3‐ferrocenyl Prop‐2‐en‐1‐one Derivatives

Corrigendum: A Visible-Light-Induced Strategy to Construct Osmanaphthalynes, Osmaanthracyne, and Osmaphenanthryne.

Corrigendum: Chiral Phosphoric Acid‐Catalyzed Asymmetric Aza‐Friedel–Crafts Reaction of Indoles with Cyclic N‐Acylketimines: Enantioselective Synthesis of Trifluoromethyldihydroquinazolines

Stereoselective Asymmetric Syntheses of Molecules with a 4,5-Dihydro-1H-[1,2,4]-Triazoline Core Possessing an Acetylated Carbohydrate Appendage: Crystal Structure, Spectroscopy, and Pharmacology

Correction: Novel Strategies for Catalytic Asymmetric Synthesis of C1-chiral 1,2,3,4-Tetrahydroisoquinolines and 3,4-Dihydrotetrahydroisoquinolines

Correction: Synthesis of Indoles and Quinazolines Via Additive-Controlled Selective C–H Activation/annulation of N-arylamidines and Sulfoxonium Ylides

Corrigendum: Regio‐ and Stereospecific O‐Glycosylation of Phenolic Compounds Catalyzed by a Fungal Glycosyltransferase from Mucor Hiemalis

Correction: Synthesis and Immunological Evaluation of MUC1 Glycopeptide Conjugates Bearing N-acetyl Modified STn Derivatives As Anticancer Vaccines.